Photodynamic therapy

Dermatologic Clinics

Volumn 32, Issue 3, 2014, Pages 415-425

  Rkein, Ali M ^a   Ozog, David M ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Aminolevulinic acid; Light based therapies; Methyl aminolevulinate; Nonmelanoma skin cancer; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTIINFECTIVE AGENT; LOCAL ANESTHETIC AGENT; OXYGEN; OXYGEN RADICAL; PHOTOACTIVE PORPHYRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; PHOTOSENSITIZING AGENT;

ACNE VULGARIS; ACTINIC KERATOSIS; APOPTOSIS; BASAL CELL CARCINOMA; BLUE LIGHT; BOWEN DISEASE; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COOLING; HISTORY OF MEDICINE; HUMAN; IMMUNE DEFICIENCY; INCUBATION TIME; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PHOTOAGING; PHOTODYNAMIC THERAPY; PHOTOREJUVENATION; PHOTOTOXICITY; PIGMENT DISORDER; PRIORITY JOURNAL; RED LIGHT; REJUVENATION; REVIEW; SCAR FORMATION; SKIN CANCER; SKIN INFECTION; SKIN PAIN; SUPERFICIAL NONMELANOMA SKIN CANCER; TREATMENT INDICATION; TREATMENT OUTCOME; VERRUCA VULGARIS; VISUAL ANALOG SCALE; PHOTOCHEMOTHERAPY; PROCEDURES; SKIN DISEASES;

HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES;

EID: 84901601275     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2014.03.009     Document Type: Review

References (37)

1. Rivard J., Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol 2006, 5(6):556-561.
2. Babilas P., Schreml S., Landthaler M., et al. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed 2010, 26(3):118-132.
3. Szeimies R.M., Drager J., Abels C., et al. History of photodynamic therapy in dermatology. Photodynamic therapy and fluorescence diagnosis in dermatology 2001, 3-16. Elsevier, Amsterdam.
4. Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990, 6(1-2):143-148.
5. Babilas P., Travnik R., Werner A., et al. Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges 2008, 6:25-32.
6. Gold M.H., Bradshaw V.L., Boring M.M., et al. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006, 32:795-801. [discussion: 801-3].
7. Hongcharu W., Taylor C.R., Chang Y., et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000, 115:183-192.
8. Itoh Y., Ninomiya Y., Tajima S., et al. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001, 144:575-579.
9. Wiegell S.R., Wulf H.C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, con-trolled trial. Br J Dermatol 2006, 154:969-976.
10. Wiegell S.R., Wulf H.C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 2006, 54:647-651.
11. Sakamoto F.H., Torezan L., Anderson R.R. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice Part 2 Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol 2010, 63:195-211.
12. Stender I.M., Na R., Fogh H., et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000, 355:963-966.
13. Schroeter C.A., Kaas L., Waterval J.J., et al. Successful treatment of periungual warts using photodynamic therapy: a pilot study. J Eur Acad Dermatol Venereol 2007, 21:1170-1174.
14. Stefanaki I.M., Georgiou S., Themelis G.C., et al. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. Br J Dermatol 2003, 149:972-976.
15. Fehr M.K., Hornung P., Schwarz V.A., et al. Photodynamic therapy of vulvar and vaginal condylomata and intraepithelial neoplasia using topical 5-aminolaevulinic acid. Lasers Surg Med 2002, 30:273-279.
16. Morton C., Campbell S., Gupta G., et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006, 155:1029-1036.
17. Touma D., Yaar M., Whitehead S., et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004, 140:33-40.
18. Gupta A.K., Paquet M., Villanueva E., et al. Interventions for actinic keratoses. Cochrane Database Syst Rev 2012, (12). CD004415.
19. Tierney E.P., Eide M.J., Jacobsen G., et al. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther 2008, 10(2):81-86.
20. Morton C., Horn M., Leman J., et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006, 142:729-735.
21. Salim A., Leman J.A., McColl J.H., et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003, 148:539-543.
22. Morton C.A., MacKie R.M., Whitehurst C., et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998, 134:248-249.
23. Szeimies R.M., Ibbotson S., Murrell D.F., et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008, 22:1302-1311.
24. Liu A., Moy R.L., Ross E.V., et al. Pulsed dye laser and pulsed dye laser-mediated photodynamic therapy in the treatment of dermatologic disorders. Dermatol Surg 2012, 38(3):351-366.
25. Chaves Y., Torezan L., Niwa A.B., et al. Pain in photodynamic therapy: mechanism of action and management strategies. An Bras Dermatol 2012, 87(4):521-526. [quiz: 527-9].
26. Stangeland K.Z., Kroon S. Cold air analgesia as pain reduction during photodynamic therapy of actinic keratosis. J Eur Acad Dermatol Venereol 2012, 26(7):849-854.
27. Tyrrell J., Campbell S.M., Curnow A. The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy. J Photochem Photobiol B 2011, 103(1):1-7.
28. Paoli J., Halldin C., Ericson M.B., et al. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol 2008, 33(5):559-564.
29. Serra-Guillen C., Hueso L., Nagore E., et al. Comparative study between cold air analgesia and supraorbital and supratrochlear nerve block for the management of pain during photodynamic therapy for actinic keratoses of the frontotemporal zone. Br J Dermatol 2009, 161(2):353-356.
30. Wiegell S.R., Haedersdal M., Wulf H.C. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009, 89:145-149.
31. Lehmann P. Side effects of topical photodynamic therapy. Hautarzt 2007, 58:597-603.
32. Brooke R.C.C., Sinha A., Sidhu M.K., et al. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. J Invest Dermatol 2006, 126:2296-2301.
33. Ibbotson S.H. Adverse effects of topical photodynamic therapy. Photodermatol Photoimmunol Photomed 2011, 27(3):116-130.
34. Kaae J., Philipsen P.A., Haedersdal M., et al. Immediate whealing urticaria in red light exposed areas during photodynamic therapy. Acta Derm Venereol 2008, 88(5):480-483.
35. Wolfe C.M., Hatfield K., Cognetta A.B. Cellulitis as a postprocedural complication of topical 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis. J Drugs Dermatol 2007, 6:544-548.
36. Hayami J., Okamoto H., Sugihara A., et al. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol 2007, 34:320-327.
37. Finlan L.E., Kernohan N.M., Thomson G., et al. Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen plus ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo. Br J Dermatol 2005, 153:1001-1010.